Background: Overweight adults are at increased risk for cardiovascular disease and vitamin D
Introduction
Vitamin D deficiency is essentially pandemic, with an estimated one billion people affected worldwide [1] . Apart from its well-established role in calcium and phosphorus homeostasis, vitamin D deficiency has been implicated with adverse extra-skeletal health outcomes, including cardiovascular disease (CVD) [2] . Based on the results of a recent umbrella review, there is suggestive evidence for an association between increased serum vitamin D levels and lower risk of type II diabetes mellitus, hypertension and cardiovascular disease [3] . NHANES III, a cross-sectional study, found an adjusted hazard ratio for CVD mortality of 2.36 (95% confidence intervals 1.17 to 4.75) after seven years of follow-up, for subjects with 25(OH)D levels below 25 nmol/L compared to those with levels over 100 nmol/L [4] . One more observational study that followed-up 10,000 adults 50 to 74 years old for approximately seven years, showed that subjects with vitamin D deficiency had a 27% increased risk of total CVD as well as a 62% increased risk for fatal CVD [5] .
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Adults with overweight or obesity are at increased risk for both vitamin D deficiency [6] and CVD [7] . A recent systematic review by the authors highlighted a paucity of vitamin D interventional studies with cardiometabolic risk factors as outcomes among otherwise healthy overweight and obese adults [8] . Within this context, whether vitamin D status improvement, as part of an interventional protocol, exerts sexual dimorphism in pathways associated with cardiovascular disease at the serum protein level has not been examined to date. Recent studies, including the authors', have demonstrated that vitamin D disposition manifests marked sexual dimorphism, also evident through its effects on sex hormone metabolism [9] [10] [11] [12] .
Recent notable reviews report on the increasing utility of proteomics to various aspects of nutrition research [13, 14] . In particular, non-targeted, global proteomics could be used to identify novel targets of response to a nutritional intervention at the tissue or serum/plasma level, thus forming the basis to a "hypothesis-generating" strategy [15] . Also, proteomics could be used for the "hypothesis-driven" analysis of a priori selected proteins. A targeted proteomics pipeline has been used in a recent vitamin D observational study examining how vitamin D status differentially affects the expression of 54 high-abundant plasma proteins between hormonal contraceptive users and nonusers [16] . To date, no studies have reported the non-targeted quantitative analysis of serum proteins that become altered consequent to a vitamin D intervention protocol. This is, in part, consequent to the technically challenging task of effectively analysing the serum proteome to elucidate clinically relevant protein markers [17] .
The principle aim of this study was to compare the effects of vitamin D status correction on serum proteins associated with cardiovascular risk, between age-and BMI-matched overweight males and pre-menopausal females using the author's in-depth proteome analysis of non-depleted whole serum [10, 18, 19] .
Materials and Methods

Recruitment of participants and intervention
Reporting of this study conforms to the STROBE statement and the broader EQUATOR guidelines [20] . The authors [21] This article is protected by copyright. All rights reserved.
the study in compliance with the Global Physical Activity Questionnaire developed by the WHO [24] (Supplementary section 2). All participants completed the 12-month intervention.
Anthropometry and blood collection
Participants were asked to visit their local PHCC physician and/or nurse on duty after overnight fasting (>10 hours) for anthropometry and blood withdrawal. Anthropometry included height (rounded off to the nearest 0.5 cm), weight (rounded off to the nearest 0.1 kg) and mean systolic and diastolic pressure (average of three readings). Body mass index was calculated as weight 
Biochemical analyses
Fasting glucose and lipid profile were measured using a chemical analyser (Konelab, Espoo, Finland). Serum 25(OH)D levels were measured by a specific enzyme-linked immunosorbent assay (IDS, Tyne and Wear, UK). The inter-and intra-assay variability of this assay was 5.2% and 4.5%, respectively.
Clinical data analysis
Clinical data were analysed using the Social Sciences version 16.0 (SPSS, Chicago, IL). All parameters are presented as mean ± standard deviation. A paired Student T-test was used to compare within group differences between baseline and 12 months after the intervention. Significance was set at p-value ≤ 0.05.
Serum procurement and proteomic analysis
The procurement and handling of sera was in accordance to the recommendations of the Standard Operating Procedure Integration Working Group (SOPIWG) [25] . The serum specimens were thawed and vortexed for 2 minutes. At baseline and after the 12-month intervention, individual 50 μL aliquots from all female participants were randomly selected and combined in two master pools as biological replicates (n=12 per pool at baseline and at 12-months). The same procedure was applied to sera from male participants (n=13 per pool at baseline and at 12-months). subjected to depletion-free, quantitative serum proteomic analysis using our previously published methodology [10, 18, 19] . Briefly, a 100 μL aliquot from each master pool was mixed with 400 μL mobile phase solution (6 M guanidine hydrochloride in 9:1 V/V water: methanol) and subjected to high-performance Size Exclusion Chromatography. The separated protein segments were dialysis purified and lyophilized to dryness at 4 °C. An amount of 100μg of protein from each of the corresponding master pools was subjected to trypsin proteolysis and their proteolytic peptides were iTRAQ labeled, pooled, and offline fractionated with high pH C 8 reverse phase chromatography. Each fraction was then analysed with ultra-high performance low pH C 18 nano-liquid chromatographyhigh-resolution tandem mass spectrometry with the FT-Orbitrap platform as reported before [26] [27] [28] [29] [30] .
Unprocessed raw files were submitted to Proteome Discoverer 1.4 for target decoy searching against the UniProtKB Homo Sapiens database (release date 10-Jan-2015) with SequestHT as reported before. Reporter ion ratios from unique peptides only were considered for the quantitation of the respective protein. Quantification ratios were median-normalized and log 2 transformed. A protein was considered differentially expressed between the male and female groups after intervention relative to baseline when its 2-group T-Test p-value was ≤ 0.05. Only proteins identified with at least two unique peptides were further considered for bioinformatics analysis in compliance with the Paris
Publication Guidelines for the analysis and documentation of peptide and protein identifications
(http://www.mcponline.org/site/misc/ParisReport_Final.xhtml) and the recently published guidelines for high-confidence protein identification [31] . The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [32] partner repository with the dataset identifier PXD003663.
Principal component analysis and protein hierarchical clustering analysis
Principal component analysis using the reporter ion ratios of all analyzed proteins after the 12-month intervention compared to baseline was performed using BioConductor-R (version 2.15.1) and g-plots in R (version 3.1.2). Hierarchical clustering analysis visualized in heatmap format using the differentially expressed proteins between the male and female groups after the 12-month intervention compared to baseline was performed using the Cluster 3.0 (http://bonsai.hgc.jp/ mdehoon/software/cluster/software.htm) and the Java Treeview software (http://jtreeview.sourceforge.net). The clustering parameters were iteratively determined to be: correlation (Euclidean distance) metrics and complete linkage method using the normalized log2ratios
for each protein.
Pathway Map analysis
The in silico functional interpretation of the modulated serum proteome between the male and female groups was conducted with the pathway map analysis feature of MetaCore (GeneGo, St.
Joseph, MI, US). A hypergeometric test was used for the identification of canonical pathway maps
that were enriched in the differentially expressed serum proteins between sexes (Benjamini−Hochberg FDR-corrected, p-value ≤ 0.05).
This article is protected by copyright. All rights reserved. were performed on individual serum samples of females and males at baseline and after the 12-month intervention following the manufacturer's instructions. These subjects were randomly selected from the cohort using the randomization function of Excel, Microsoft Office 2011. Due to insufficient sample volume from certain subjects, the number of serum samples analysed for each ELISA measurement were as follows: vitamin-K dependent protein C (n=23 females and n=23 males); von Willebrand factor; Fibrinogen gamma chain (n=20 females and n=20 males) and multimerin-1 (n=22 females and n=22 males). Delta values of change (end-of-study minus baseline) were compared between female and male participants using a heteroscedastic two-group T-Test. Significance was set at p-value ≤ 0.05.
Results
The participants' clinical characteristics, sun exposure, physical activity and nutritional assessment data at baseline and after the 12-month intervention are detailed in Table 1 . Serum 25(OH)D levels was the only assessed clinical indicator that changed significantly as a result of the intervention. With the exception of vitamin D intake and sun exposure, there was no significant change in physical activity levels, total energy, macronutrient and micronutrient intake between baseline and end-of-study for both female and male groups ( Table 1) .
Only proteins identified at ≥ 95% confidence (FDR corrected p-value ≤ 0.05 at the peptide level) were accounted for. A total of 1,841 unique proteins were fully quantified across all eight conditions of the multiplex experiment (Supplementary Table 1 ). Principal component analysis of This article is protected by copyright. All rights reserved.
the reporter ion ratios of analysed proteins showed that females clustered separately from males ( Figure 1A) , suggesting that vitamin D status improvement exerts sexually dimorphic effects at the serum protein level.
A total of 282 proteins identified with at least two unique peptides were differentially expressed after the intervention between females and males (p-value ≤ 0.05) (Supplementary Table   2 ). These are visualized in heatmap format in Figure 1B . This article is protected by copyright. All rights reserved.
Discussion
The present non-targeted serum proteomics prospective interventional study showed that vitamin D status improvement among overweight adults exerts sex-specific effects on proteins participating in the blood coagulation pathway. To date, only few studies have examined the sex specificity of the pleiotropic actions of vitamin D. A recent cross-sectional study reported sexually dimorphic trends between vitamin D status and its role in conditioning the severity of coronary artery disease [33] . Interestingly, this study observed that lower 25(OH)D levels played a more pronounced role in conditioning the severity of coronary artery disease in females compared to males. Another cross-sectional study examined the association between vitamin D deficiency and the associated risk of developing obesity-related complications, including type II diabetes mellitus (T2DM) and insulin resistance [9] . After adjusting for confounding factors, including BMI, the study showed an inverse association of 25(OH)D with T2DM only in females, suggesting a sex-specific extra-skeletal effect of vitamin D. We have previously reported that vitamin D supplementation in patients with T2DM
improved serum concentrations of magnesium and selenium in a sex-specific manner [34] .
Two different parameters could in isolation or synergistically explain this sexually dimorphic vitamin D action and its effect to blood coagulation. Firstly, our group has shown previously that among overweight/obese adults, males exhibited higher circulating levels of proteins involved in the blood coagulation pathway relative to females [10] . Secondly, this same study provided protein level evidence of the increased conversion of 25-hydroxyvitamin D to the active metabolite 1,25-hydroxyvitamin D in men compared to women. These traits may be linked to the effects of sex hormone metabolism on vitamin D disposition [35, 36] and the blood coagulation system [37] [38] [39] . In accordance to the current mandates of the U. S. National Institutes of Health (NIH), sex specific differences in the metabolism and disposition of vitamin D should be taken into consideration in cell and animal studies [40] .
A potential limitation to the experimental study design was the sample pooling for each clinical condition examined. To overcome this limitation, key proteins were validated with ELISA in individual serum samples from the same clinical cohort. Another limitation to this study is the physiological interpretation of the sexual dimorphic trend observed. Such an investigation was beyond the scope of this study. Finally, the number of subjects that participated in the present proofof-principle study is rather small and a non-treated control group was not included, thus further confirmation of our findings in randomized control trials including larger number of normal weight as well as overweight/obese subjects is warranted.
Conclusions and Future Outlook
The quantitative serum proteomics approach used in this study revealed a sexually dimorphic effect of vitamin D status correction on proteins participating in blood coagulation among overweight adults. These sex-mediated vitamin D effects should be factored in the design and interpretation of vitamin D observational and interventional studies testing cardiometabolic outcomes.
